• Info
  • Insider Ownership

Insider Trading & Ownership of Hannah Valantine

Location
Menlo Park, CA
Summary
The estimated net worth of Hannah Valantine is at least $1,307,499 dollars as of 14 Nov 2025. Hannah Valantine is the Director of CareDx, Inc. and owns shares of CareDx, Inc. (CDNA) stock worth about $747.3K. Hannah Valantine is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $513.9K. Hannah Valantine is the Director of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. and owns shares of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) stock worth about $46.3K.
Signature
/s/ Will Solis, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Hannah Valantine files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Hannah Valantine

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CDNA CareDx, Inc. Director $747,288 -$202,566 -21% 18 Jun 2025
BBIO BridgeBio Pharma, Inc. Director $513,884 -$2,482,235 -83% 12 Nov 2025
PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Director $46,327 04 Jun 2025

Insider Transactions Reported by Hannah Valantine:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.